Almost all of the recent clinical guidelines for CHB have the same recommendations for antiviral therapy [8,15,18,22,23] based on high serum values of alanine aminotransferase (ALT) and HBV DNA in CHB patients with no liver cirrhosis. The gene discussed is GPT; the disease is cirrhosis of liver.